Literature DB >> 25935001

Epigenetic regulation of differential HLA-A allelic expression levels.

Veron Ramsuran1, Smita Kulkarni2, Colm O'huigin3, Yuko Yuki3, Danillo G Augusto1, Xiaojiang Gao3, Mary Carrington4.   

Abstract

MHC class I expression levels influence the strength of immune responses and represent another variable in determining outcome to disease beyond peptide binding alone. Identification of the HLA loci that vary in allelic expression levels and delineating the mechanism responsible for expression variation may provide the opportunity to modify their expression therapeutically. We have examined the expression levels of allelic lineages at the HLA-A locus in a sample of 216 European Americans using a real-time polymerase chain reaction assay, which amplifies all HLA-A lineages specifically with equal efficiency, and observed a gradient of expression that associates with HLA-A allelic lineage (R = 0.6, P = 5 × 10(-25)). DNA methylation of the HLA-A gene appears to contribute to the variation in HLA-A mRNA expression levels, as a significant inverse correlation was observed between HLA-A mRNA expression levels in untreated cells and the degree to which expression is increased after treatment of the cells with a DNA methyltransferase inhibitor (R = 0.6, P = 2.8 × 10(-6)). Further, deep-sequencing and immunoprecipitation assays revealed allelic lineage-specific methylation patterns within the HLA-A promoter region where increased DNA methylation levels correlated significantly with reduced HLA-A expression levels (R = 0.89, P = 3.7 × 10(-9)). These data demonstrate HLA-A allelic lineage-specific variation in expression levels, and DNA methylation as a likely factor in contributing to this variation. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25935001      PMCID: PMC4492392          DOI: 10.1093/hmg/ddv158

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

Review 1.  Allele-specific DNA methylation: beyond imprinting.

Authors:  Benjamin Tycko
Journal:  Hum Mol Genet       Date:  2010-09-20       Impact factor: 6.150

2.  The molecular origin and consequences of escape from miRNA regulation by HLA-C alleles.

Authors:  Colm O'huigin; Smita Kulkarni; Yunping Xu; Zhihui Deng; Judith Kidd; Kenneth Kidd; Xiaojiang Gao; Mary Carrington
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

Review 3.  CTCF function is modulated by neighboring DNA binding factors.

Authors:  Oliver Weth; Rainer Renkawitz
Journal:  Biochem Cell Biol       Date:  2011-09-07       Impact factor: 3.626

4.  High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphism.

Authors:  Marie-Eve Blais; Yonghong Zhang; Tim Rostron; Harry Griffin; Stephen Taylor; Keyi Xu; Huiping Yan; Hao Wu; Ian James; Mina John; Tao Dong; Sarah L Rowland-Jones
Journal:  J Immunol       Date:  2012-04-02       Impact factor: 5.422

Review 5.  Immunogenetics of spontaneous control of HIV.

Authors:  Mary Carrington; Bruce D Walker
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

6.  The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation.

Authors:  N Cereb; S Y Yang
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

7.  Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns.

Authors:  Felix Bormann; Christine Sers; Barbara Seliger; Diana Handke; Thomas Bergmann; Stephanie Seibt; Hans Lehrach; Andreas Dahl
Journal:  Mol Genet Genomics       Date:  2011-08-31       Impact factor: 3.291

8.  A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.

Authors:  Rasmi Thomas; Chloe L Thio; Richard Apps; Ying Qi; Xiaojiang Gao; Darlene Marti; Judy L Stein; Kelly A Soderberg; M Anthony Moody; James J Goedert; Gregory D Kirk; W Keith Hoots; Steven Wolinsky; Mary Carrington
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

9.  Differential microRNA regulation of HLA-C expression and its association with HIV control.

Authors:  Smita Kulkarni; Ram Savan; Ying Qi; Xiaojiang Gao; Yuko Yuki; Sara E Bass; Maureen P Martin; Peter Hunt; Steven G Deeks; Amalio Telenti; Florencia Pereyra; David Goldstein; Steven Wolinsky; Bruce Walker; Howard A Young; Mary Carrington
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

10.  DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project.

Authors:  Vardhman K Rakyan; Thomas Hildmann; Karen L Novik; Jörn Lewin; Jörg Tost; Antony V Cox; T Dan Andrews; Kevin L Howe; Thomas Otto; Alexander Olek; Judith Fischer; Ivo G Gut; Kurt Berlin; Stephan Beck
Journal:  PLoS Biol       Date:  2004-11-23       Impact factor: 8.029

View more
  39 in total

1.  Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Authors:  Veron Ramsuran; Pedro G Hernández-Sanchez; Colm O'hUigin; Gaurav Sharma; Niamh Spence; Danillo G Augusto; Xiaojiang Gao; Christian A García-Sepúlveda; Gurvinder Kaur; Narinder K Mehra; Mary Carrington
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

2.  NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.

Authors:  Tamara Tilburgs; Torsten B Meissner; Leonardo M R Ferreira; Arend Mulder; Kiran Musunuru; Junqiang Ye; Jack L Strominger
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

Review 3.  The MHC in the era of next-generation sequencing: Implications for bridging structure with function.

Authors:  Effie W Petersdorf; Colm O'hUigin
Journal:  Hum Immunol       Date:  2018-10-12       Impact factor: 2.850

4.  HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.

Authors:  Kattria van der Ploeg; Jean-Benoît Le Luduec; Philip A Stevenson; Soo Park; Ted A Gooley; Effie W Petersdorf; Brian C Shaffer; Katharine C Hsu
Journal:  Blood Adv       Date:  2020-10-13

5.  Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.

Authors:  Tatsuya Imi; Takamasa Katagiri; Kazuyoshi Hosomichi; Yoshitaka Zaimoku; Viet Hoang Nguyen; Noriharu Nakagawa; Atsushi Tajima; Tetsuichi Yoshizato; Seishi Ogawa; Shinji Nakao
Journal:  Blood Adv       Date:  2018-05-08

6.  SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions.

Authors:  Wanding Zhou; Timothy J Triche; Peter W Laird; Hui Shen
Journal:  Nucleic Acids Res       Date:  2018-11-16       Impact factor: 16.971

7.  Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip.

Authors:  Smita Kulkarni; Veron Ramsuran; Marijana Rucevic; Sukhvinder Singh; Alexandra Lied; Viraj Kulkarni; Colm O'hUigin; Sylvie Le Gall; Mary Carrington
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

8.  Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

Authors:  Effie W Petersdorf; Mary Carrington; Colm O'hUigin; Mats Bengtsson; Dianne De Santis; Valerie Dubois; Ted Gooley; Mary Horowitz; Katharine Hsu; J Alejandro Madrigal; Martin J Maiers; Mari Malkki; Caroline McKallor; Yasuo Morishima; Machteld Oudshoorn; Stephen R Spellman; Jean Villard; Phil Stevenson
Journal:  Lancet Haematol       Date:  2019-10-25       Impact factor: 18.959

Review 9.  Polymorphisms of HLA-B: influences on assembly and immunity.

Authors:  Eli Olson; Jie Geng; Malini Raghavan
Journal:  Curr Opin Immunol       Date:  2020-06-30       Impact factor: 7.486

Review 10.  The emerging role of epigenetic therapeutics in immuno-oncology.

Authors:  Michael J Topper; Michelle Vaz; Kristen A Marrone; Julie R Brahmer; Stephen B Baylin
Journal:  Nat Rev Clin Oncol       Date:  2019-09-23       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.